Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
138.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 6.50 (4.71%)
Market Cap: £108.29m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

19 Apr 2010 07:00

RNS Number : 3236K
Xaar PLC
19 April 2010
 



 

 

 

FOR IMMEDIATE RELEASE

19 April 2010

 

 

 

Xaar plc

 

 

INTERIM MANAGEMENT STATEMENT

 

 

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 January 2010 to 31 March 2010.

 

Trading and margins for the first quarter of the year were in line with the Board's expectations. Sales of Platform 1 ("P1") products have shown more stability than seen in recent periods and the increased demand for Platform 3 ("P3") products, first reported for the fourth quarter of last year, has continued. During Q1 2010, P3 demand continued to grow; the company is investing to increase output from the Huntingdon plant by mid-year.

 

The increase in P3 sales continues to be driven by volume sales into the industrial and packaging markets. We continue to work with our customers in these and other end markets to deliver levels of performance to allow them to move their printing machinery products to volume launch. We are still incurring some additional costs associated with new product introductions; however these are expected to reduce later this year as previously stated.

 

The consolidation of the Group's manufacturing facilities into a single plant in Huntingdon, England continues to progress according to schedule with the costs and benefits of the project remaining in line with the original plan.

 

The Group's balance sheet is strong with net cash at 31 March 2010 of £9.2m (31 December 2009: £11.1m).

 

The Board is encouraged by the rate of adoption of the Group's P3 products in new markets and remains satisfied with the relative stability of P1 sales in Xaar's traditional markets. The Board is now looking forward to volume sales of both P3 and new P1 products across a wider range of customers and end markets together with the reduction of new product support costs.

 

 

Ends

 

 

 

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Steve Liebmann or Andy Harris

020-7367-8883 / 07802-888159

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBBGDSBUBBGGL
Date   Source Headline
1st Apr 20202:49 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSConfirmation of Board Changes and Succession
23rd Mar 20205:47 pmRNSTrading Statement-COVID-19 & Preliminary Statement
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 20208:41 amRNSHolding(s) in Company
2nd Mar 202011:38 amRNSTotal Voting Rights
25th Feb 20207:41 amRNSHolding(s) in Company
18th Feb 20201:04 pmRNSHolding(s) in Company
13th Feb 20204:57 pmRNSHolding(s) in Company
12th Feb 20205:25 pmRNSHolding(s) in Company
3rd Feb 202012:41 pmRNSTotal Voting Rights
16th Jan 20207:00 amRNSTrading Statement
9th Jan 20207:00 amRNSDirectorate Change
8th Jan 202011:09 amRNSHolding(s) in Company
3rd Jan 20203:32 pmRNSBlock listing Interim Review
2nd Jan 20202:15 pmRNSTotal Voting Rights
10th Dec 20193:51 pmRNSHolding(s) in Company
4th Dec 20194:53 pmRNSCompletion of Investment by Stratasys in Xaar 3D
2nd Dec 20195:39 pmRNSTotal Voting Rights
27th Nov 201910:35 amRNSResult of General Meeting
19th Nov 20199:23 amRNSHolding(s) in Company
18th Nov 20193:32 pmRNSHolding(s) in Company
8th Nov 20194:15 pmRNSPublication - Circular & Notice of General Meeting
1st Nov 201912:50 pmRNSTotal Voting Rights
23rd Oct 20198:30 amRNSHolding(s) in Company
23rd Oct 20198:30 amRNSHolding(s) in Company
11th Oct 20197:00 amRNSCEO Succession
8th Oct 20193:33 pmRNSHolding(s) in Company
8th Oct 20192:46 pmRNSHolding(s) in Company
7th Oct 201912:57 pmRNSGrant of Options
3rd Oct 20191:54 pmRNSHolding(s) in Company
1st Oct 20195:20 pmRNSTotal Voting Rights
1st Oct 20199:10 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSBoard Changes and Succession
26th Sep 20197:00 amRNS2019 Interim Results
12th Sep 20197:00 amRNSProposed investment by Stratasys in Xaar 3D
3rd Sep 20197:00 amRNSTrading update & revised date for interim results
2nd Sep 201910:45 amRNSTotal Voting Rights
1st Aug 201910:39 amRNSTotal Voting Rights
31st Jul 201912:07 pmRNSSecond Price Monitoring Extn
31st Jul 201912:02 pmRNSPrice Monitoring Extension
26th Jul 20199:36 amRNSChange of Auditor
8th Jul 20197:00 amRNSScheduled Trading Statement
4th Jul 20195:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jul 20193:04 pmRNSTotal Voting Rights
5th Jun 20195:05 pmRNSTotal Voting Rights
28th May 201911:41 amRNSHolding(s) in Company
28th May 20199:08 amRNSHolding(s) in Company
21st May 20193:55 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.